Organisation paid for research Program year 2025 Source: CMS Open Payments

NWN Univ

Neither a doctor nor a teaching hospital

Research payments

$723,317

136 payments

Through program year 2025, NWN Univ is reported as receiving $723,317 in research payments, across 136 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$162,353	46
2024	Research	$184,085	31
2023	Research	$116,834	16
2022	Research	$181,762	9
2021	Research	$52,263	28
2020	Research	$613	1
2019	Research	$25,407	5

Breakdown

Who paid Research payments · program years 2019–2025

Boehringer Ingelheim International GmbH $312,581 38 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $218,355 26 payments
Janssen Research & Development, LLC $126,073 45 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $63,130 22 payments
Boehringer Ingelheim RCV GmbH & Co KG $3,178 5 payments

Studies the money was for Research payments · program years 2019–2025

DCRI Registry Study $166,344 8 payments
Empa Kidney $122,562 3 payments
A first-in-human Phase I, non-randomized, open-label, multi-center dose-escalation trial of BI 765049 and BI 765049 + ezabenlimab administered by parenteral administration(s) in patients with malignant solid tumors expressing B7-H6. $82,307 10 payments
Idiopathic Pulmonary Fibrosis Prospective Outcome Registry $37,587 12 payments
EYE-DMI Epidemiology Study $36,581 17 payments
Proof of Clinical Principal in Crohn's Disease $32,871 2 payments
EYE DMI Epidemiology Study $32,150 2 payments
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation $25,320 13 payments
Empa-Kidney $24,865 2 payments
78934804Crd2001 $24,450 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.